Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000049.xml
Download PDF
Clin Colon Rectal Surg 2015; 28(04): 262-270
DOI: 10.1055/s-0035-1564435
DOI: 10.1055/s-0035-1564435
Surveillance and Survivorship after Treatment for Colon Cancer
Further Information
Publication History
Publication Date:
22 November 2015 (online)
Abstract
Colorectal cancer is the third most common cancer diagnosed in the United States. Majority of patients have localized disease that is amenable to curative resection. Disease recurrence remains a major concern after resection. In addition, patients are at an increased risk for developing a second or metachronous colon cancer. The principal goal of surveillance following treatment of colon cancer is to improve disease-free and overall survival. Survivorship is a distinct phase following surveillance to help improve quality of life and promote longevity.
-
References
- 1 Anthony T, Simmang C, Hyman N , et al; Standards Practice Task Force, The American Society of Colon and Rectal Surgeons. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004; 47 (6) 807-817
- 2 Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003; 53 (1) 5-26
- 3 Goldberg RM, Fleming TR, Tangen CM , et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 1998; 129 (1) 27-35
- 4 Engstrom PF, Benson III AB, Saltz L ; National Comprehensive Cancer Network. Colon cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2003; 1 (1) 40-53
- 5 Engstrom PF, Benson III AB, Saltz L ; National Comprehensive Cancer Network. Rectal cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2003; 1 (1) 54-63
- 6 Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995; 38 (6) 619-626
- 7 Mäkelä JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995; 130 (10) 1062-1067
- 8 Kjeldsen BJ, Kronborg O, Fenger C, Jørgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997; 84 (5) 666-669
- 9 Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998; 114 (1) 7-14
- 10 Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998; 41 (9) 1127-1133
- 11 Secco GB, Fardelli R, Gianquinto D , et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002; 28 (4) 418-423
- 12 Primrose JN, Perera R, Gray A , et al; FACS Trial Investigators. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 2014; 311 (3) 263-270
- 13 Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324 (7341) 813-813
- 14 Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2007; (1) CD002200
- 15 Figueredo A, Rumble RB, Maroun J , et al; Follow-up of patients with curatively resected colorectal cancer: a practice guideline. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. BMC Cancer 2003; 3: 26
- 16 Rosen M, Chan L, Beart Jr RW, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998; 41 (9) 1116-1126
- 17 Pfister DG, Benson III AB, Somerfield MR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med 2004; 350 (23) 2375-2382
- 18 Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998; 228 (1) 59-63
- 19 Stiggelbout AM, de Haes JC, Vree R , et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997; 75 (6) 914-920
- 20 Wattchow DA, Weller DP, Esterman A , et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006; 94 (8) 1116-1121
- 21 Peethambaram P, Weiss M, Loprinzi CL , et al. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology 1997; 54 (4) 287-292
- 22 Graffner H, Hultberg B, Johansson B, Möller T, Petersson BG. Detection of recurrent cancer of the colon and rectum. J Surg Oncol 1985; 28 (2) 156-159
- 23 Ahlquist DA, Wieand HS, Moertel CG , et al. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA 1993; 269 (10) 1262-1267
- 24 Jahn H, Joergensen OD, Kronborg O, Fenger C. Can Hemoccult-II replace colonoscopy in surveillance after radical surgery for colorectal cancer and after polypectomy?. Dis Colon Rectum 1992; 35 (3) 253-256
- 25 Locker GY, Hamilton S, Harris J , et al; ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 24 (33) 5313-5327
- 26 Park YJ, Park KJ, Park JG, Lee KU, Choe KJ, Kim JP. Prognostic factors in 2230 Korean colorectal cancer patients: analysis of consecutively operated cases. World J Surg 1999; 23 (7) 721-726
- 27 Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270 (8) 943-947
- 28 Lennon T, Houghton J, Northover JM , et al. What is the value of clinical follow-up for colorectal cancer patients?. The experience of the CRC/NIH CEA second-look trial—Proceedings of the Nottingham International Colorectal Cancer Symposium, Nottingham; 1995
- 29 Northover J, Houghton J, Lennon T. CEA to detect recurrence of colon cancer. JAMA 1994; 272 (1) 31
- 30 Litvak A, Cercek A, Segal N , et al. False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. J Natl Compr Canc Netw 2014; 12 (6) 907-913
- 31 Ding P, Liska D, Tang P , et al. Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective study. Ann Surg 2012; 256 (1) 111-116
- 32 Li Destri G, Di Cataldo A, Puleo S. Colorectal cancer follow-up: useful or useless?. Surg Oncol 2006; 15 (1) 1-12
- 33 Glover C, Douse P, Kane P , et al. Accuracy of investigations for asymptomatic colorectal
liver metastases. Dis Colon Rectum 2002; 45 (4) 476-484
MissingFormLabel
- 34 Child PW, Yan TD, Perera DS, Morris DL. Surveillance-detected hepatic metastases from colorectal cancer had a survival advantage in seven-year follow-up. Dis Colon Rectum 2005; 48 (4) 744-748
- 35 Rex DK, Kahi CJ, Levin B , et al. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin 2006; 56 (3) 160-167 , quiz 185–186
- 36 Nash GM, Weiss A, Dasgupta R, Gonen M, Guillem JG, Wong WD. Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum 2010; 53 (10) 1365-1373
- 37 Green RJ, Metlay JP, Propert K , et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med 2002; 136 (4) 261-269
- 38 Earle C, Annis R, Sussman J, Haynes AE, Vafaei A. Follow-up Care, Surveillance Protocol, and Secondary Prevention Measures for Survival of Colorectal Cancer. Toronto, ON: Cancer Care Ontario; 2012
- 39 Rowland JH. What are cancer survivors telling us?. Cancer J 2008; 14 (6) 361-368
- 40 Labianca R, Nordlinger B, Beretta GD , et al; ESMO Guidelines Working Group. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl. 06) vi64-vi72
- 41 Baker F, Haffer SC, Denniston M. Health-related quality of life of cancer and noncancer patients in Medicare managed care. Cancer 2003; 97 (3) 674-681
- 42 Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer 2008; 112 (11, Suppl): 2577-2592
- 43 Denlinger CS, Barsevick AM. The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 2009; 7 (8) 883-893 , quiz 894
- 44 Kurtz ME, Kurtz JC, Stommel M, Given CW, Given B. Predictors of depressive symptomatology of geriatric patients with colorectal cancer: a longitudinal view. Support Care Cancer 2002; 10 (6) 494-501
- 45 Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. J Clin Oncol 2013; 31 (21) 2699-2707
- 46 Gami B, Harrington K, Blake P , et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther 2003; 18 (10) 987-994
- 47 Meyerhardt JA, Sato K, Niedzwiecki D , et al. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst 2012; 104 (22) 1702-1711
- 48 Meyerhardt JA, Heseltine D, Niedzwiecki D , et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006; 24 (22) 3535-3541
- 49 Meyerhardt JA, Giovannucci EL, Ogino S , et al. Physical activity and male colorectal cancer survival. Arch Intern Med 2009; 169 (22) 2102-2108
- 50 Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol 2013; 31 (7) 876-885
- 51 Kuiper JG, Phipps AI, Neuhouser ML , et al. Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 2012; 23 (12) 1939-1948
- 52 Je Y, Jeon JY, Giovannucci EL, Meyerhardt JA. Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies. Int J Cancer 2013; 133 (8) 1905-1913
- 53 Dignam JJ, Polite BN, Yothers G , et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006; 98 (22) 1647-1654
- 54 Sinicrope FA, Foster NR, Yoon HH , et al. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials. J Clin Oncol 2012; 30 (4) 406-412
- 55 Sinicrope FA, Foster NR, Yothers G , et al; Adjuvant Colon Cancer Endpoints (ACCENT) Group. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 2013; 119 (8) 1528-1536
- 56 Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 2012; 30 (1) 42-52
- 57 Meyerhardt JA, Niedzwiecki D, Hollis D , et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA 2007; 298 (7) 754-764
- 58 Kushi LH, Byers T, Doyle C , et al; American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2006; 56 (5) 254-281 , quiz 313–314
- 59 Jansen L, Herrmann A, Stegmaier C, Singer S, Brenner H, Arndt V. Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol 2011; 29 (24) 3263-3269
- 60 Meyerhardt JA, Mangu PB, Flynn PJ , et al; American Society of Clinical Oncology. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol 2013; 31 (35) 4465-4470
- 61 Faul LA, Shibata D, Townsend I, Jacobsen PB. Improving survivorship care for patients with colorectal cancer. Cancer Contr 2010; 17 (1) 35-43
- 62 Hewitt M, Greenfield S, Stovall E , eds. From Cancer Patient to Cancer Survivor: Lost in Transition. Committee on Cancer Survivorship: Improving Care and Quality of Life. Institute of Medicine and National Research Council: National Academy of Sciences; 2006
- 63 McCullough ML, Gapstur SM, Shah R, Jacobs EJ, Campbell PT. Association between red and processed meat intake and mortality among colorectal cancer survivors. J Clin Oncol 2013; 31 (22) 2773-2782
- 64 Phipps AI, Shi Q, Newcomb PA , et al. Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147. J Clin Oncol 2013; 31 (16) 2016-2023
- 65 Benson III AB, Bekaii-Saab T, Chan E , et al; National Comprehensive Cancer Network. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2013; 11 (5) 519-528
- 66 Earle CC, Neville BA. Under use of necessary care among cancer survivors. Cancer 2004; 101 (8) 1712-1719